Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1025 of 5804
-
Could a daily millet porridge reshape your gut and tame metabolic syndrome?
Disease control Recruiting nowDietary fiber are components in foods that are not digested by human gastrointestinal enzymes (alpha amylase and alpha glucosidase) but are instead broken down and fermented by gut microbes. The byproducts generated during fermentation in the large intestine, primarily short-chai…
Phase: NA • Sponsor: JSS MEDICAL COLLEGE, JSS ACADEMY OF HIGHER EDUCATION AND RESEARCH • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Steroid showdown: can prednisolone save lungs in rare fibrotic disease?
Disease control Not yet recruitingHypersensitivity Pneumonitis (HP) is an immune-mediated disease that manifests as interstitial lung disease after exposure to an inhaled antigen, often unidentified. HP can be classified as non-fibrotic or fibrotic HP. Fibrotic HP is associated with impaired quality of life (QoL)…
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Could a repurposed drug boost brain recovery after severe injury?
Disease control ENROLLING_BY_INVITATIONThe purpose of this study is to determine if experimental drug treatment improves recovery after TBI as compared to a control (placebo) group. Changes in recovery will be measured throughout the study. The study drug listed below is approved by the U.S. Food and Drug Administrati…
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New pill aims to slow vision loss in dry AMD
Disease control Not yet recruitingThis is a parallel, randomized, open-label, controlled study to evaluate the efficacy and safety of oral EG-301 in patients with intermediate non-exudative (dry) age-related macular degeneration (dAMD). Ninety patients will be randomly allocated in a 2:1 ratio to one of two trea…
Phase: PHASE2 • Sponsor: Evergreen Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could a night of brain zapping improve sleep and seizures in epilepsy?
Symptom relief Not yet recruitingThe goal of this clinical trial is to gauge whether overnight, non-invasive temporal interference (TI) stimulation aimed at the hippocampus can reduce abnormal brain activity linked to seizures and improve sleep in adults with drug-resistant temporal lobe epilepsy. The main quest…
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Teen liver crisis: diet trial offers hope
Disease control Recruiting nowThis phase 2 trial is a single-site sequential, multiple assignment, randomized trial (SMART) to test and construct a high-quality adaptive intervention of essential amino acids (EAA) and/or Low Sugar Diet for children with metabolic dysfunction associated steatotic liver disease…
Phase: PHASE2 • Sponsor: Michigan State University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a gut bacteria transplant ease heart failure in seniors?
Disease control Not yet recruitingThis is a single-center, randomized, double-blind, placebo-controlled trial designed to evaluate the efficacy and safety of fecal microbiota transplantation (FMT) in elderly patients with heart failure with preserved ejection fraction (HFpEF). HFpEF is a common type of heart fai…
Phase: PHASE1, PHASE2 • Sponsor: The First Affiliated Hospital of Air Force Medicial University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New shot aims to reverse liver scarring in MASH patients
Disease control Not yet recruitingThis is a Phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-design clinical trial to evaluate efficacy and safety of QL2401 in patients with metabolic dysfunction-associated steatohepatitis and liver fibrosis (F2-F3).
Phase: PHASE2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can a smartphone game ease eating disorder symptoms in young women?
Symptom relief Not yet recruitingThe goal of this clinical trial is to test whether a new digital intervention decreases eating disorder symptoms in young women and girls at risk by changing how they experience thoughts and feelings about their body. The digital intervention is based on Acceptance and Commitmen…
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
New biopsy method may spare breast cancer patients from unnecessary surgery
Diagnosis Not yet recruitingNeoadjuvant chemotherapy is widely used in the treatment of locally advanced breast cancer or in early stages of triple-negative or HER2 overexpressing tumors. Pathological complete response (pCR) to neoadjuvant chemotherapy is associated with better clinical outcomes. However, c…
Phase: NA • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
Could a single iron infusion help heart failure patients feel better?
Symptom relief ENROLLING_BY_INVITATIONThis study will investigate whether intravenous (IV) iron improves symptoms, exercise capacity, and quality of life in patients with heart failure with preserved ejection fraction (HFpEF) and iron deficiency. Iron deficiency is common in heart failure and is associated with wors…
Phase: PHASE2 • Sponsor: Government of Jersey • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New hope for kids with weak hearts: long-term safety study launched
Disease control Recruiting nowResearchers are looking for a better way to treat children and young adults who have heart failure with left ventricular systolic dysfunction (LVSD). Heart failure with left ventricular systolic dysfunction (LVSD) is a condition where the left side of the heart is weak and strugg…
Phase: PHASE3 • Sponsor: Bayer • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New drug IDP-001 takes on advanced cancers in early trial
Disease control Not yet recruitingThis clinical study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of IDP-001 in participants with advanced or metastatic squamous and non-squamous NSCLC and other squamous cell solid tumors (for example, head and neck, esophage…
Phase: PHASE1, PHASE2 • Sponsor: InduPro, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can pressurized oxygen boost stroke recovery?
Disease control Recruiting nowThe purpose of this RCT trial is to evaluate whether the sequential hyperbaric oxygen therapy can improve the 90-day functional outcome in patients with acute large vessel occlusion ischemic stroke after endovascular treatment.
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New shot could ease stuffy noses and polyps for sinusitis sufferers
Disease control Not yet recruitingThis is an open-label, single-arm, multicenter, extension study to evaluate the safety and efficacy of CM512 in patients With Chronic Rhinosinusitis with Nasal Polyposis
Phase: PHASE2 • Sponsor: Keymed Biosciences Co.Ltd • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Which drug works best for shock? major trial to settle debate
Disease control Not yet recruitingThe goal of this multicenter, open-label, randomized clinical trial is to learn whether norepinephrine or dopamine is more effective and safer as the first-line vasoactive drug for treating cardiogenic shock in adults. Cardiogenic shock is a life-threatening condition in which th…
Phase: NA • Sponsor: Chonnam National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New Long-Acting shot aims to tame acromegaly in phase 3 trial
Disease control Not yet recruitinghe purpose of this study is to evaluate the efficacy and safety of SYHX2008 injection in in patients with acromegaly.
Phase: PHASE3 • Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for stubborn high blood pressure? phase 3 trial launches
Disease control Not yet recruitingAprocitentan tablets are currently the only endothelin dual receptor antagonist approved internationally for the treatment of resistant hypertension.This is a multicenter, randomized, double-blind, placebo-controlled Phase 3 study to evaluate the efficacy and safety of aprocitent…
Phase: PHASE3 • Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New injection aims to tame chronic hepatitis b
Disease control Not yet recruitingThis is a multicenter, open-label, non-randomized, Phase 1 clinical study with single-dose and multiple-dose dose-escalation cohorts. The study is designed to evaluate the safety, tolerability, and pharmacokinetic characteristics of TVAX-028 in patients with chronic hepatitis B v…
Phase: PHASE1 • Sponsor: Grand Theravac Life Sciences (Nanjing) Co., Ltd. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New drug cocktail aims to boost kidney cancer surgery success
Disease control Not yet recruitingEvaluation of long-term renal function improvement, surgical safety, as well as efficacy and safety of preoperative anlotinib hydrochloride capsules combined with benmelstobart injection versus surgery in patients with localized renal cell carcinoma undergoing partial nephrectomy
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC